Overview

Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary goal of this post marketing surveillance (PMS) study is to document the efficacy of Tiotropium (Spiriva) to improve physical activity measured by a score that is recommended in national chronic obstructive pulmonary disease (COPD) guidelines for monitoring the course of the disease.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tiotropium Bromide